| Code | 96068 | ||||||||||
| MA number | 59/0170/87-CS | ||||||||||
| Product Form: | sus inj 1x0,5 ml (liek.inj.skl.) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | National | ||||||||||
| MAH, country: | GlaxoSmithKline Biologicals S.A., Belgium | ||||||||||
| Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Route of admin.: | Intramuscular use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 8(3) application - new active substance |
| MA issued: | 18.02.1988 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| SPC: |
SPC_ENGERIX-B 10 mcg_06.2023.pdf
|
| PIL: |
PIL_ENGERIX-B 10 mcg_ ENGERIX-B 20 mcg_06.2023.pdf
|
| Safety feature | Yes |
| Data update: | 22.05.2018 |
